Morgan Stanley Sight Sciences, Inc. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 223,858 shares of SGHT stock, worth $817,081. This represents 0.0% of its overall portfolio holdings.
Number of Shares
223,858
Previous 163,505
36.91%
Holding current value
$817,081
Previous $1.09 Million
29.36%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding SGHT
# of Institutions
81Shares Held
21.6MCall Options Held
66.8KPut Options Held
13K-
Kck Ltd. Tortola, D84.65MShares$17 Million22.26% of portfolio
-
Ubs Group Ag2.53MShares$9.24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.12MShares$7.74 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.1MShares$7.68 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$6.17 Million0.0% of portfolio
About Sight Sciences, Inc.
- Ticker SGHT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,826,200
- Market Cap $175M
- Description
- Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...